— Know what they know.
/
Not Investment Advice

ADMA NASDAQ

ADMA Biologics, Inc.
1W: -0.5% 1M: -22.7% 3M: -47.5% YTD: -52.7% 1Y: -58.6% 3Y: +107.3% 5Y: +391.9%
$8.24
-0.22 (-2.60%)
 
Weekly Expected Move ±9.6%
$7 $7 $8 $9 $10
NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Sell · Power 34 · $1.9B mcap · 227M float · 3.20% daily turnover · Short 37% of daily vol
Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings
Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest Supply Chain

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
51.4 / 100
NoneWeakNarrowWide
Primary source: Switching Costs  ·  ROIC: 35.3%  ·  5Y Avg: 2.4%
Cost Advantage
59
Intangibles
40
Switching Cost
65
Network Effect
62
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ADMA shows a Weak competitive edge (51.4/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Switching Costs. ROIC of 35.3% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$18
Low
$18
Avg Target
$18
High
Based on 1 analyst since May 6, 2026 earnings
Analyst Recommendations
Strong Buy: 1Buy: 8Hold: 1Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$21.00
Analysts3
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-07 Canaccord Genuity Gary Nachman $21 $18 -3 +78.6% $10.08
2026-04-20 Canaccord Genuity — Initiated $21 — +93.0% $10.88
2026-04-13 Mizuho Securities Anthony Petrone $14 $24 +10 +132.3% $10.33
2024-10-14 H.C. Wainwright Raghuram Selvaraju $4 $18 +14 +5.0% $17.14
2024-06-20 Mizuho Securities Anthony Petrone $6 $14 +8 +31.8% $10.62
2023-01-03 H.C. Wainwright — $4 $4 +0 +16.0% $3.88
2022-11-10 Mizuho Securities — Initiated $6 — +96.7% $3.05
2022-07-25 H.C. Wainwright — Initiated $4 — +84.3% $2.17

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
May 22, 2026
DCF
1
ROE
5
ROA
5
D/E
2
P/E
2
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ADMA receives an overall rating of B. Strongest factors: ROE (5/5), ROA (5/5). Areas of concern: DCF (1/5), D/E (2/5), P/E (2/5), P/B (1/5).
Rating Change History
DateFromTo
2026-05-18 B+ B
2026-05-14 B B+
2026-05-12 B+ B
2026-05-11 B B+
2026-05-07 C- B
2026-05-06 B C-
2026-02-26 B+ B
2026-02-18 B B+
2026-02-12 B+ B
2026-02-09 B B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 66 Grade A+
Profitability
100
Balance Sheet
87
Earnings Quality
48
Growth
37
Value
68
Momentum
49
Safety
100
Cash Flow
73
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ADMA scores highest in Safety (100/100) and lowest in Growth (37/100). An overall grade of A+ places ADMA among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
11.13
Safe Zone
Piotroski F-Score
6/9
✓ ✓ ✗ ✗ ✓ ✓ ✓ ✓ ✗
Beneish M-Score
-0.39
Possible Manipulator
Ohlson O-Score
-11.21
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AAA
Score: 96.8/100
Trend: Improving
Earnings Quality
50/100
OCF/NI: 0.78x
Accruals: 6.7%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ADMA scores 11.13, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ADMA scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ADMA's score of -0.39 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ADMA's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ADMA receives an estimated rating of AAA (score: 96.8/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). ADMA's score of 50/100 is moderate — some divergence between reported earnings and underlying cash flows.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
11.76x
PEG
-0.57x
P/S
3.75x
P/B
4.98x
P/FCF
20.04x
P/OCF
16.85x
EV/EBITDA
10.13x
EV/Revenue
4.23x
EV/EBIT
10.53x
EV/FCF
19.96x
Earnings Yield
7.65%
FCF Yield
4.99%
Shareholder Yield
7.50%
Graham Number
$5.55
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 11.8x earnings, ADMA trades at a reasonable valuation. An earnings yield of 7.6% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $5.55 per share, 48% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.801
NI / EBT
×
Interest Burden
1.008
EBT / EBIT
×
EBIT Margin
0.401
EBIT / Rev
×
Asset Turnover
0.916
Rev / Assets
×
Equity Multiplier
1.347
Assets / Equity
=
ROE
40.0%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ADMA's ROE of 40.0% is driven by Asset Turnover (0.916), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$5.86
Price/Value
1.54x
Margin of Safety
-53.82%
Premium
53.82%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with ADMA's realized 0.0% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. ADMA trades at a 54% premium to its adjusted intrinsic value of $5.86, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 11.8x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$8.24
Median 1Y
$7.38
5th Pctile
$2.45
95th Pctile
$22.53
Ann. Volatility
67.6%
Analyst Target
$21.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Adam S. Grossman
President, Chief Executive Officer and Director
 $925,000 $4,049,994 $10,237,326
Kaitlin Kestenberg Operating
rating Officer & Senior Vice President, Compliance
 $575,000 $1,249,989 $3,488,647
Brad L. Tade
Former Executive Vice President and Chief Financial Officer
 $500,000 $999,988 $2,823,630
Paul Terence Kohler,
Jr. Current Chief Financial Officer and Treasurer
 $19,231 $1,124,988 $2,296,949

CEO Pay Ratio

224:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $10,237,326
Avg Employee Cost (SGA/emp): $45,790
Employees: 2,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
2,000
+66.7% YoY
Revenue / Employee
$255,087
Rev: $510,173,000
Profit / Employee
$73,465
NI: $146,930,000
SGA / Employee
$45,790
Avg labor cost proxy
R&D / Employee
$2,381
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -1.3% -1.3% -62.5% -68.2% -63.8% -61.3% -45.0% -32.5% -27.5% -15.6% -19.7% -2.5% 24.2% 47.4% 81.6% 85.4% 86.3% 86.5% 35.6% 40.0% 40.02%
ROA -44.0% -44.5% -29.6% -32.4% -30.2% -29.1% -21.1% -15.3% -12.9% -7.3% -8.3% -1.1% 10.3% 20.1% 48.3% 50.6% 51.1% 51.2% 26.4% 29.7% 29.72%
ROIC -37.5% -37.9% -23.9% -23.8% -21.1% -19.0% -14.1% -9.1% -6.0% 0.5% 7.6% 15.5% 33.1% 47.4% 66.6% 68.1% 68.4% 68.5% 32.8% 35.3% 35.30%
ROCE -32.5% -32.8% -23.8% -26.4% -23.8% -21.7% -15.1% -8.3% -5.4% 0.6% -1.1% 7.0% 21.2% 32.4% 32.2% 35.3% 35.8% 37.9% 34.2% 36.9% 36.89%
Gross Margin -5.6% 1.9% 13.3% 12.6% 22.9% 23.5% 28.4% 29.0% 27.8% 36.6% 42.1% 47.8% 53.6% 49.8% 53.9% 53.2% 55.1% 56.3% 63.8% 70.5% 70.53%
Operating Margin -87.4% -69.8% -50.0% -50.9% -27.1% -22.7% -12.1% -1.4% -0.8% 12.9% 19.3% 26.7% 36.6% 33.1% 32.6% 30.4% 35.1% 38.0% 45.1% 43.9% 43.93%
Net Margin -1.1% -85.7% -63.1% -85.9% -40.6% -36.3% -24.5% -11.9% -10.6% 3.8% -23.9% 21.7% 29.9% 30.0% 95.2% 23.4% 28.1% 27.1% 35.5% 39.6% 39.59%
EBITDA Margin -80.4% -62.8% -44.8% -68.8% -22.0% -18.1% -9.1% 2.4% 3.4% 16.4% -12.6% 29.7% 38.9% 35.2% 33.6% 32.6% 36.1% 38.2% 46.9% 45.5% 45.53%
FCF Margin -2.3% -1.8% -1.6% -1.3% -89.9% -76.2% -47.7% -33.7% -24.7% -10.0% 1.6% 5.7% 20.2% 20.7% 25.9% 19.7% 13.9% 8.3% 5.5% 21.2% 21.16%
OCF Margin -2.1% -1.6% -1.4% -1.1% -77.9% -65.6% -38.6% -26.5% -19.9% -6.9% 3.4% 7.5% 22.1% 22.5% 27.8% 22.0% 16.2% 13.3% 9.9% 25.2% 25.17%
ROE 3Y Avg snapshot only 30.40%
ROE 5Y Avg snapshot only 0.87%
ROA 3Y Avg snapshot only 22.56%
ROIC 3Y Avg snapshot only 27.18%
ROIC Economic snapshot only 30.31%
Cash ROA snapshot only 20.56%
Cash ROIC snapshot only 27.33%
CROIC snapshot only 22.98%
NOPAT Margin snapshot only 32.51%
Pretax Margin snapshot only 40.47%
R&D / Revenue snapshot only 1.28%
SGA / Revenue snapshot only 18.73%
SBC / Revenue snapshot only 3.02%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -2.77 -2.03 -3.56 -4.58 -5.32 -6.79 -11.94 -15.40 -20.39 -36.66 -36.17 -428.13 77.83 71.83 21.33 23.48 21.67 17.12 30.27 13.07 11.764
P/S Ratio 3.51 2.21 3.15 3.81 3.53 3.66 5.11 4.04 3.95 3.57 3.96 5.51 8.20 12.78 9.89 10.57 9.55 7.34 8.72 4.24 3.746
P/B Ratio 2.31 1.71 1.81 2.54 2.75 3.38 5.18 4.83 5.41 5.51 7.55 11.54 20.02 36.19 12.08 13.91 12.97 10.28 9.32 4.53 4.984
P/FCF -1.51 -1.21 -2.03 -3.01 -3.93 -4.80 -10.72 -12.00 -15.99 -35.61 253.61 96.73 40.63 61.64 38.18 53.56 68.83 88.07 159.88 20.04 20.037
P/OCF — — — — — — — — — — 116.08 73.24 37.08 56.87 35.54 47.96 59.02 55.20 88.26 16.85 16.849
EV/EBITDA -4.37 -3.42 -5.78 -6.93 -8.42 -11.31 -21.64 -44.28 -103.08 91.56 217.11 58.85 41.32 50.43 28.41 30.06 27.63 20.72 22.44 10.13 10.133
EV/Revenue 4.23 2.82 3.79 4.36 4.00 4.05 5.55 4.41 4.27 3.86 4.30 5.83 8.47 13.02 9.84 10.52 9.50 7.30 8.70 4.23 4.225
EV/EBIT -4.03 -3.13 -5.24 -6.31 -7.52 -9.90 -18.34 -31.25 -53.72 525.34 -345.96 84.07 47.15 54.99 30.05 31.61 29.04 21.72 23.40 10.53 10.527
EV/FCF -1.82 -1.55 -2.44 -3.45 -4.45 -5.32 -11.64 -13.11 -17.31 -38.50 275.97 102.32 41.98 62.78 37.99 53.33 68.51 87.56 159.60 19.96 19.965
Earnings Yield -36.1% -49.2% -28.1% -21.8% -18.8% -14.7% -8.4% -6.5% -4.9% -2.7% -2.8% -0.2% 1.3% 1.4% 4.7% 4.3% 4.6% 5.8% 3.3% 7.6% 7.65%
FCF Yield -66.3% -82.4% -49.4% -33.2% -25.5% -20.8% -9.3% -8.3% -6.3% -2.8% 0.4% 1.0% 2.5% 1.6% 2.6% 1.9% 1.5% 1.1% 0.6% 5.0% 4.99%
Price/Tangible Book snapshot only 4.569
EV/OCF snapshot only 16.788
EV/Gross Profit snapshot only 6.895
Acquirers Multiple snapshot only 10.414
Shareholder Yield snapshot only 7.50%
Graham Number snapshot only $5.55
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 7.71 7.71 6.87 6.87 6.87 6.87 6.89 6.89 6.89 6.89 5.16 5.16 5.16 5.16 5.97 5.97 5.97 5.97 6.71 6.71 6.708
Quick Ratio 3.62 3.62 2.77 2.77 2.77 2.77 2.73 2.73 2.73 2.73 1.69 1.69 1.69 1.69 2.90 2.90 2.90 2.90 3.74 3.74 3.739
Debt/Equity 1.11 1.11 0.73 0.73 0.73 0.73 1.02 1.02 1.02 1.02 1.05 1.05 1.05 1.05 0.24 0.24 0.24 0.24 0.17 0.17 0.167
Net Debt/Equity 0.47 0.47 0.37 0.37 0.37 0.37 0.45 0.45 0.45 0.45 0.67 0.67 0.67 0.67 -0.06 -0.06 -0.06 -0.06 -0.02 -0.02 -0.016
Debt/Assets 0.47 0.47 0.37 0.37 0.37 0.37 0.44 0.44 0.44 0.44 0.43 0.43 0.43 0.43 0.17 0.17 0.17 0.17 0.13 0.13 0.128
Debt/EBITDA -1.74 -1.73 -1.94 -1.74 -1.97 -2.20 -3.91 -8.52 -17.90 15.63 27.62 5.04 2.09 1.43 0.56 0.51 0.50 0.48 0.40 0.38 0.376
Net Debt/EBITDA -0.74 -0.74 -0.98 -0.88 -0.99 -1.11 -1.72 -3.75 -7.87 6.87 17.59 3.21 1.33 0.91 -0.14 -0.13 -0.13 -0.12 -0.04 -0.04 -0.036
Interest Coverage -4.82 -4.79 -4.49 -4.91 -4.02 -3.17 -2.42 -1.17 -0.70 0.07 -0.13 0.87 2.94 5.25 10.02 12.60 15.23 19.63 26.69 28.28 28.284
Equity Multiplier 2.35 2.35 1.96 1.96 1.96 1.96 2.29 2.29 2.29 2.29 2.43 2.43 2.43 2.43 1.40 1.40 1.40 1.40 1.31 1.31 1.308
Cash Ratio snapshot only 1.260
Debt Service Coverage snapshot only 29.385
Cash to Debt snapshot only 1.097
FCF to Debt snapshot only 1.351
Defensive Interval snapshot only 851.2 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.35 0.41 0.33 0.39 0.45 0.54 0.49 0.58 0.67 0.75 0.76 0.84 0.97 1.13 1.04 1.12 1.16 1.19 0.92 0.92 0.916
Inventory Turnover 1.00 1.13 0.77 0.85 0.92 1.03 0.83 0.93 1.05 1.13 1.01 1.02 1.06 1.16 1.21 1.27 1.30 1.29 1.15 1.05 1.048
Receivables Turnover 6.96 8.20 3.87 4.50 5.26 6.24 6.99 8.25 9.44 10.63 12.03 13.19 15.39 17.84 11.02 11.87 12.25 12.62 4.90 4.89 4.892
Payables Turnover 6.67 7.51 6.79 7.44 8.06 9.01 9.26 10.43 11.78 12.65 11.72 11.88 12.32 13.53 11.53 12.14 12.42 12.33 10.17 9.24 9.240
DSO 52 45 94 81 69 58 52 44 39 34 30 28 24 20 33 31 30 29 75 75 74.6 days
DIO 364 323 472 430 397 356 442 393 348 324 362 357 345 314 303 287 281 283 316 348 348.2 days
DPO 55 49 54 49 45 41 39 35 31 29 31 31 30 27 32 30 29 30 36 40 39.5 days
Cash Conversion Cycle 361 319 512 463 421 373 455 402 356 329 362 354 339 307 304 288 281 282 355 383 383.3 days
Fixed Asset Turnover snapshot only 7.110
Operating Cycle snapshot only 422.8 days
Cash Velocity snapshot only 5.818
Capital Intensity snapshot only 1.224
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 56.0% 70.0% 91.7% 95.5% 89.4% 90.4% 90.4% 93.5% 89.1% 79.6% 67.6% 55.7% 58.7% 63.4% 65.2% 62.2% 43.6% 27.6% 19.6% 11.0% 10.99%
Net Income -19.8% -11.2% 5.4% -4.5% 0.6% 5.5% 8.0% 39.1% 44.9% 67.5% 57.2% 92.4% 1.9% 4.0% 8.0% 57.7% 5.0% 2.1% -25.7% -20.0% -20.03%
EPS 18.8% 27.1% 49.5% 38.3% 35.5% 35.6% 18.0% 46.2% 51.4% 72.7% 61.5% 92.8% 1.8% 3.9% 7.4% 55.8% 4.9% 2.1% -25.0% -18.5% -18.46%
FCF -36.4% -24.4% -9.7% 3.9% 26.7% 20.2% 41.7% 48.5% 48.1% 76.4% 1.1% 1.3% 2.3% 4.4% 26.4% 4.6% -1.3% -48.7% -74.8% 19.1% 19.05%
EBITDA -19.6% -8.9% 11.2% -2.0% 6.8% 17.0% 25.6% 69.4% 83.5% 1.2% 1.1% 2.5% 8.8% 9.0% 27.8% 4.7% 1.4% 74.2% 34.0% 32.2% 32.22%
Op. Income -21.7% -12.4% 10.1% 8.3% 16.4% 25.5% 32.6% 56.3% 67.7% 1.0% 1.5% 2.7% 6.0% 84.7% 5.4% 2.4% 85.4% 45.4% 37.7% 36.1% 36.05%
OCF Growth snapshot only 26.78%
Asset Growth snapshot only 27.74%
Equity Growth snapshot only 36.76%
Debt Growth snapshot only -2.72%
Shares Change snapshot only -1.93%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 31.7% 40.1% 68.3% 78.7% 81.6% 82.8% 73.8% 71.6% 77.4% 79.8% 82.9% 80.6% 78.5% 77.4% 74.0% 69.7% 62.7% 55.3% 49.0% 41.0% 41.00%
Revenue 5Y 46.0% 47.4% 50.0% 53.1% 55.0% 56.1% 46.6% 49.7% 52.3% 56.5% 72.3% 76.6% 78.2% 78.1% 70.8% 66.4% 66.3% 64.7% 64.6% 60.4% 60.37%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — — — 4.7% 2.3% 1.5% 1.2% 1.0% 86.6% 86.56%
Gross Profit 5Y — — -22.9% 8.0% 42.7% — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y 24.3% 24.3% 45.9% 45.9% 45.9% 45.9% 40.0% 40.0% 40.0% 40.0% 16.6% 16.6% 16.6% 16.6% 20.9% 20.9% 20.9% 20.9% 21.5% 21.5% 21.45%
Assets 5Y 54.3% 54.3% 63.4% 63.4% 63.4% 63.4% 26.4% 26.4% 26.4% 26.4% 29.9% 29.9% 29.9% 29.9% 30.9% 30.9% 30.9% 30.9% 24.6% 24.6% 24.62%
Equity 3Y 29.8% 29.8% 92.6% 92.6% 92.6% 92.6% 79.7% 79.7% 79.7% 79.7% 15.3% 15.3% 15.3% 15.3% 35.2% 35.2% 35.2% 35.2% 46.4% 46.4% 46.45%
Book Value 3Y -9.8% -8.8% 22.3% 19.1% 23.8% 29.2% 19.3% 24.5% 31.0% 29.6% -13.2% -9.2% -6.9% -5.8% 22.0% 25.6% 25.0% 25.7% 37.7% 42.7% 42.68%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.80 0.80 0.79 0.80 0.79 0.78 0.73 0.74 0.76 0.79 0.84 0.87 0.87 0.87 0.87 0.88 0.92 0.95 0.96 0.97 0.965
Earnings Stability 0.83 0.88 0.73 0.79 0.71 0.75 0.42 0.02 0.05 0.16 0.17 0.36 0.48 0.54 0.48 0.58 0.68 0.77 0.73 0.79 0.793
Margin Stability 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.50 0.00 0.50 0.50 1.00 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1
Earnings Persistence 0.92 0.96 0.98 0.98 1.00 0.98 0.97 0.84 0.82 0.50 0.50 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness — — — — — — — — — — — — — — — — 0.00 0.00 0.71 0.78 0.777
ROE Trend 1.84 1.84 0.84 0.91 1.07 1.20 0.25 0.39 0.41 0.52 0.26 0.41 0.65 0.83 0.89 0.76 0.60 0.42 0.13 0.06 0.064
Gross Margin Trend 0.60 0.47 0.41 0.37 0.39 0.41 0.45 0.38 0.29 0.27 0.22 0.23 0.25 0.24 0.23 0.20 0.16 0.15 0.14 0.15 0.153
FCF Margin Trend 0.79 1.26 1.17 1.30 1.59 1.39 1.66 1.58 1.36 1.19 1.03 0.86 0.77 0.64 0.49 0.34 0.16 0.03 -0.08 0.08 0.085
Sustainable Growth Rate — — — — — — — — — — — — 24.2% 47.4% 81.6% 85.4% 86.3% 86.5% 35.6% 40.0% 40.02%
Internal Growth Rate — — — — — — — — — — — — 11.4% 25.2% 93.6% 1.0% 1.0% 1.0% 35.9% 42.3% 42.28%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 1.65 1.49 1.57 1.34 1.17 1.22 0.90 1.01 1.03 0.71 -0.31 -5.85 2.10 1.26 0.60 0.49 0.37 0.31 0.34 0.78 0.776
FCF/OCF 1.11 1.12 1.12 1.13 1.15 1.16 1.23 1.27 1.24 1.45 0.46 0.76 0.91 0.92 0.93 0.90 0.86 0.63 0.55 0.84 0.841
FCF/Net Income snapshot only 0.653
OCF/EBITDA snapshot only 0.604
CapEx/Revenue 23.3% 19.6% 16.7% 14.7% 12.0% 10.6% 9.0% 7.2% 4.8% 3.1% 1.8% 1.8% 1.9% 1.7% 1.9% 2.3% 2.3% 5.0% 4.4% 4.0% 4.00%
CapEx/Depreciation snapshot only 2.563
Accruals Ratio 0.29 0.22 0.17 0.11 0.05 0.06 -0.02 0.00 0.00 -0.02 -0.11 -0.07 -0.11 -0.05 0.19 0.26 0.32 0.35 0.17 0.07 0.067
Sloan Accruals snapshot only 0.203
Cash Flow Adequacy snapshot only 6.285
Earnings Quality Score snapshot only 0.500
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio — — — — — — — — — — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio — — — — — — — — — — — — 9.7% 4.7% 1.9% 4.1% 3.8% 14.8% 26.7% 98.1% 98.05%
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.1% 0.2% 0.1% 0.2% 0.1% 0.0% 0.0% 0.1% 0.1% 0.1% 0.1% 0.2% 0.2% 0.9% 0.9% 7.5% 7.50%
Net Buyback Yield -49.8% -65.6% -47.5% -22.1% -15.9% -11.1% -8.1% -8.6% -7.8% -7.7% 0.0% 0.1% 0.1% -0.1% -0.0% 0.1% 0.0% 0.8% 0.8% 7.3% 7.34%
Total Shareholder Return -49.8% -65.6% -47.5% -22.1% -15.9% -11.1% -8.1% -8.6% -7.8% -7.7% 0.0% 0.1% 0.1% -0.1% -0.0% 0.1% 0.0% 0.8% 0.8% 7.3% 7.34%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.20 0.89 0.93 1.57 1.47 1.44 1.34 0.80 0.80 0.801
Interest Burden (EBT/EBIT) 1.21 1.21 1.22 1.20 1.25 1.32 1.41 1.86 2.43 -13.25 8.79 -0.16 0.66 0.81 0.90 0.92 0.93 0.95 0.96 1.01 1.008
EBIT Margin -1.05 -0.90 -0.72 -0.69 -0.53 -0.41 -0.30 -0.14 -0.08 0.01 -0.01 0.07 0.18 0.24 0.33 0.33 0.33 0.34 0.37 0.40 0.401
Asset Turnover 0.35 0.41 0.33 0.39 0.45 0.54 0.49 0.58 0.67 0.75 0.76 0.84 0.97 1.13 1.04 1.12 1.16 1.19 0.92 0.92 0.916
Equity Multiplier 2.93 2.93 2.11 2.11 2.11 2.11 2.13 2.13 2.13 2.13 2.36 2.36 2.36 2.36 1.69 1.69 1.69 1.69 1.35 1.35 1.347
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-0.58 $-0.56 $-0.40 $-0.40 $-0.37 $-0.36 $-0.32 $-0.21 $-0.18 $-0.10 $-0.12 $-0.02 $0.14 $0.28 $0.80 $0.85 $0.84 $0.86 $0.60 $0.69 $0.69
Book Value/Share $0.69 $0.66 $0.78 $0.72 $0.72 $0.72 $0.75 $0.68 $0.68 $0.65 $0.60 $0.57 $0.56 $0.55 $1.42 $1.43 $1.40 $1.43 $1.96 $1.99 $1.65
Tangible Book/Share $0.65 $0.62 $0.75 $0.69 $0.69 $0.69 $0.73 $0.66 $0.66 $0.63 $0.58 $0.55 $0.54 $0.54 $1.40 $1.41 $1.39 $1.41 $1.94 $1.97 $1.97
Revenue/Share $0.46 $0.51 $0.45 $0.48 $0.56 $0.66 $0.76 $0.82 $0.93 $1.00 $1.14 $1.20 $1.36 $1.56 $1.73 $1.88 $1.91 $2.00 $2.09 $2.12 $2.16
FCF/Share $-1.06 $-0.93 $-0.70 $-0.61 $-0.50 $-0.51 $-0.36 $-0.28 $-0.23 $-0.10 $0.02 $0.07 $0.28 $0.32 $0.45 $0.37 $0.26 $0.17 $0.11 $0.45 $0.46
OCF/Share $-0.95 $-0.83 $-0.62 $-0.54 $-0.44 $-0.44 $-0.29 $-0.22 $-0.19 $-0.07 $0.04 $0.09 $0.30 $0.35 $0.48 $0.41 $0.31 $0.27 $0.21 $0.53 $0.54
Cash/Share $0.44 $0.42 $0.28 $0.26 $0.26 $0.26 $0.43 $0.39 $0.39 $0.37 $0.23 $0.22 $0.21 $0.21 $0.42 $0.42 $0.41 $0.42 $0.36 $0.37 $0.59
EBITDA/Share $-0.44 $-0.42 $-0.29 $-0.30 $-0.27 $-0.24 $-0.19 $-0.08 $-0.04 $0.04 $0.02 $0.12 $0.28 $0.40 $0.60 $0.66 $0.66 $0.70 $0.81 $0.89 $0.89
Debt/Share $0.77 $0.73 $0.57 $0.53 $0.52 $0.52 $0.76 $0.70 $0.69 $0.66 $0.63 $0.60 $0.58 $0.58 $0.33 $0.34 $0.33 $0.34 $0.33 $0.33 $0.33
Net Debt/Share $0.33 $0.31 $0.29 $0.26 $0.26 $0.26 $0.33 $0.31 $0.31 $0.29 $0.40 $0.38 $0.37 $0.37 $-0.09 $-0.09 $-0.08 $-0.09 $-0.03 $-0.03 $-0.03
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 11.128
Altman Z-Prime snapshot only 20.981
Piotroski F-Score 5 5 4 4 4 4 6 5 5 6 5 5 6 6 7 7 7 8 7 6 6
Beneish M-Score 6.77 -4.77 -2.77 -2.03 -1.90 -1.65 -2.66 -2.52 -2.47 -2.77 -2.55 -2.42 -2.55 -2.16 1.47 1.74 2.06 2.15 -0.15 -0.39 -0.394
Ohlson O-Score snapshot only -11.210
ROIC (Greenblatt) snapshot only 43.66%
Net-Net WC snapshot only $1.33
EVA snapshot only $118814024.18
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only AAA
Credit Score 26.30 26.68 27.56 27.97 34.76 35.09 39.71 39.60 46.08 38.57 41.86 60.25 79.05 86.15 92.78 92.80 95.08 95.89 99.37 96.76 96.760
Credit Grade snapshot only 1
Credit Trend snapshot only 3.963
Implied Spread (bps) snapshot only 50.000
Industry Credit Rank snapshot only 95
Sector Credit Rank snapshot only 92

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms